{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:28:46Z","timestamp":1767148126037,"version":"build-2238731810"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rbmo.2019.07.031","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:46:48Z","timestamp":1563882408000},"page":"770-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Repeated GnRH agonist doses for luteal support: a proof of concept"],"prefix":"10.1016","volume":"39","author":[{"given":"Amir","family":"Wiser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat Hershko","family":"Klement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Shavit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Berkovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni Rahav","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Amichay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.07.031_bib0001","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(97)81908-5","article-title":"Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome","volume":"67","author":"Abramov","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0002","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1093\/humrep\/13.10.2718","article-title":"Peripheral arterial vasodilation hypothesis: A new insight into the pathogenesis of ovarian hyperstimulation syndrome","volume":"13","author":"Balasch","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0003","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.fertnstert.2016.04.004","article-title":"Intranasal gonadotropin-releasing hormone agonist (gnrha) for luteal-phase support following gnrha triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders","volume":"106","author":"Bar-Hava","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0004","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/det125","article-title":"Low-dose hcg supplementation after gnrh agonist triggering: Don't be too quick on the trigger","volume":"28","author":"Bodri","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"Chen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0006","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","article-title":"Disappearance of exogenously administered human chorionic gonadotropin","volume":"52","author":"Damewood","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0007","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An ohss-free clinic by segmentation of ivf treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0008","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: Towards a single blastocyst transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0009","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2006.12.006","article-title":"Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles","volume":"88","author":"Griesinger","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0010","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"Griesinger","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0011","doi-asserted-by":"crossref","first-page":"396","DOI":"10.14740\/jocmr2500w","article-title":"Is it possible to prevent ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist triggering and modified luteal support in patients with polycystic ovarian morphology?","volume":"8","author":"Gurbuz","year":"2016","journal-title":"J Clin Med Re"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0012","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"Gnrh agonist (buserelin) or hcg for ovulation induction in gnrh antagonist ivf\/icsi cycles: A prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0013","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 iu human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: A prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"Gnrh agonist for triggering of final oocyte maturation: Time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0015","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"Gnrha trigger and individualized luteal phase hcg support according to ovarian response to stimulation: Two prospective randomized controlled multi-centre studies in ivf patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0016","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0018","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.rbmo.2015.09.001","article-title":"\u2018Luteal coasting\u2019 after gnrh agonist trigger - individualized, hcg-based, progesterone-free luteal support in \u2018high responders\u2019: A case series","volume":"31","author":"Kol","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0030-1265677","article-title":"Gonadotropin-releasing hormone agonist trigger: The way to eliminate ovarian hyperstimulation syndrome\u2013a 20-year experience","volume":"28","author":"Kol","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0020","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when gnrh agonist is used for triggering final oocyte maturation instead of hcg in patients undergoing ivf with gnrh antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0021","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jcma.2014.07.001","article-title":"Luteal phase support with decapeptyl improves pregnancy outcomes in intracytoplasmic sperm injection with higher basal follicle-stimulating hormone or lower mature oocytes","volume":"77","author":"Kung","year":"2014","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.rbmo.2017.09.014","article-title":"Gnrha trigger and luteal coasting: A new approach for the ovarian hyperstimulation syndrome high-risk patient?","volume":"36","author":"Lawrenz","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0023","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/humrep\/deh830","article-title":"Gnrh agonist as novel luteal support: Results of a randomized, parallel group, feasibility study using intranasal administration of buserelin","volume":"20","author":"Pirard","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/727569","article-title":"Contribution to more patient-friendly art treatment: Efficacy of continuous low-dose gnrh agonist as the only luteal support-results of a prospective, randomized, comparative study","author":"Pirard","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000479557","article-title":"Number of oocytes retrieved as a criterion for \u201cfreeze-all\u201d strategy versus a single \u201crescue\u201d bolus of low-dose human chorionic gonadotropin following gnrh agonist for ovulation triggering: A pilot study","volume":"83","author":"Rahav Koren","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0026","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0027","first-page":"3319","article-title":"Dynamic changes in the intrafollicular inhibin\/activin\/follistatin axis during human follicular development: Relationship to circulating hormone concentrations","volume":"85","author":"Schneyer","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0028","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following gnrh agonist trigger with the addition of 1500 iu hcg","volume":"28","author":"Seyhan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0029","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/107155760100800603","article-title":"Gonadotropins and the uterus: Is there a gonad-independent pathway?","volume":"8","author":"Stewart","year":"2001","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0030","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/humrep\/del173","article-title":"Beneficial effect of luteal-phase gnrh agonist administration on embryo implantation after icsi in both gnrh agonist- and antagonist-treated ovarian stimulation cycles","volume":"21","author":"Tesarik","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1472-6483(10)61729-4","article-title":"Luteinizing hormone affects uterine receptivity independently of ovarian function","volume":"7","author":"Tesarik","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0032","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1210\/jcem-28-12-1763","article-title":"Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man","volume":"28","author":"Yen","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2019.07.031_bib0033","article-title":"Gonadotropin-releasing hormone agonist versus hcg for oocyte triggering in antagonist-assisted reproductive technology","volume":"10","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"updated-by":[{"DOI":"10.1016\/j.rbmo.2019.12.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000}}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319306649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319306649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T17:29:35Z","timestamp":1573147775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319306649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1472648319306649"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.07.031","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated GnRH agonist doses for luteal support: a proof of concept","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}